Pravat K Mandal

Prof. Pravat K Mandal


Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2023 in ACS Chemical Neuroscience
Verified
Journal Article
Open access
RRRimil Guha Roy
Rimil Guha Roy
PMPravat K Mandal
Pravat K Mandal
JMJoseph C. Maroon
Joseph C. Maroon
Alzheimer's disease (AD) is an insidious and progressive neurodegenerative disorder that affects millions of people worldwide. Although the pathogenesis remains obscure, there are two dominant causal hypotheses. Since last three decades, amyloid beta (Aβ) deposition was the most prominent hypothesis, and the other is the tau hyperphosphorylation hypothesis. The confirmed diagnostic criterion for AD is the presence of neurofibrillary tangles (NFTs) composed of hyperphosphorylated tau and the deposition of toxic oligomeric Aβ in the autopsied brain. Consistent with these hypotheses, oxidative stress (OS) is garnering major attention in AD research. OS results from an imbalance of pro-oxidants and antioxidants. There is a considerable debate in the scientific community on which process occurs first, OS or plaque deposition/tau hyperphosphorylation. Based on recent scientific observations of various laboratories including ours along with critical analysis of those information, we believe that OS is the early event that leads to oligomeric Aβ deposition as well as dimerization of tau protein and its subsequent hyperphosphorylation. This OS hypothesis immediately suggests the consideration of novel therapeutic approaches to include antioxidants involving glutathione enrichment in the brain by supplementation with or without an iron chelator.

1 January 2012 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
PMPravat K Mandal
Pravat K Mandal
MTManjari Tripathi
Manjari Tripathi
SSSreedevi Sugunan
Sreedevi Sugunan

15 April 2020 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
DDDivya Dwivedi
Divya Dwivedi
KMKanu Megha
Kanu Megha
RMRitwick Mishra
Ritwick Mishra
PMPravat K Mandal
Pravat K Mandal

23 August 2018 in Frontiers in Computational Neuroscience
Verified
Journal Article
Open access
PDF file
PMPravat K Mandal
Pravat K Mandal
ABAnwesha Banerjee
Anwesha Banerjee
MTManjari Tripathi
Manjari Tripathi
ASAnkita Sharma
Ankita Sharma
Neural oscillations were established with their association with neurophysiological activities and the altered rhythmic patterns are believed to be linked directly to the progression of cognitive decline. Magnetoencephalography (MEG) is a non-invasive technique to record such neuronal activity due to excellent temporal and fair amount of spatial resolution. Single channel, connectivity as well as brain network analysis using MEG data in resting state and task-based experiments were analyzed from existing literature. Single channel analysis studies reported a less complex, more regular and predictable oscillations in Alzheimer's disease (AD) primarily in the left parietal, temporal and occipital regions. Investigations on both functional connectivity (FC) and effective (EC) connectivity analysis demonstrated a loss of connectivity in AD compared to healthy control (HC) subjects found in higher frequency bands. It has been reported from multiplex network of MEG study in AD in the affected regions of hippocampus, posterior default mode network (DMN) and occipital areas, however, conclusions cannot be drawn due to limited availability of clinical literature. Potential utilization of high spatial resolution in MEG likely to provide information related to in-depth brain functioning and underlying factors responsible for changes in neuronal waves in AD. This review is a comprehensive report to investigate diagnostic biomarkers for AD may be identified by from MEG data. It is also important to note that MEG data can also be utilized for the same pursuit in combination with other imaging modalities.

18 September 2012 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
PMPravat K Mandal
Pravat K Mandal
RMRashima Mahajan
Rashima Mahajan
IDIvo D. Dinov
Ivo D. Dinov
Structural magnetic resonance imaging (MRI) provides anatomical information about the brain in healthy as well as in diseased conditions. On the other hand, functional MRI (fMRI) provides information on the brain activity during performance of a spec

18 September 2012 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PMPravat K Mandal
Pravat K Mandal
JJJitesh Joshi
Jitesh Joshi
SSSumiti Saharan
Sumiti Saharan
In recent years, the focus of research on Alzheimer's disease (AD) has shifted toward finding reliable diagnostic biomarkers that enable accurate detection of mild cognitive impairment (MCI) as well as AD. Functional magnetic resonance imaging (fMRI) has the potential to identify functional changes in the preclinical stages of AD. In addition to the cardinal deficits in memory, deficits in visuospatial cognition are pervasive in AD. Recent neurophysiological and imaging studies have revealed that changes in visuospatial perception (VSP) functions can be detected in the early stages of AD. This review highlights the scope of VSP functional alterations as a biomarker for AD. We describe the neuroanatomical regions involved in the processing of various VSP tasks, and discuss the effect of AD on these regions from a pathological as well as a functional point of view. A comprehensive synopsis of the existing fMRI literature that has assessed VSP in patients with MCI and AD has been provided. The diagnostic scope of monitoring the brain activation correlates of VSP processing in AD is discussed in terms of the key advantages of utilizing VSP-related deficits in AD for early detection and longitudinal tracking of AD.